GOED finally gets its wish, with EPA and DHA omega-3s now up for official review in the United States and Canada.
A U.S. and Canadian nutrient assessment group has tabbed omega-3 EPA and DHA for its next round of Dietary Reference Intake (DRI) reviews. The two fatty acids are, thus, one step closer to earning Recommended Daily Intake (RDI) values.
The Global Organization for EPA and DHA Omega-3s (Salt Lake City) broke the news last Friday in its members-only newsletter, having spent years petitioning the Institute of Medicine and FDA to schedule these reviews. Industry will still have to wait for a 2015 workshop in which experts will mull potential DRI values while keeping in mind chronic disease outcomes, such as coronary disease risk, that may be related to intake of (or, rather, deficiency in) these nutrients.
The nutrient assessment group that is scheduling EPA and DHA for DRI reviews also selected sodium, magnesium, and vitamin E as “priority nutrients” for assessment. Each of these nutrients was selected based on the opinion that new scientific information has been made available to warrant new DRI reviews. Only time will tell which nutrients make the final cut.
Other organizations around the world already have dietary recommendations for EPA, DHA, and fish intake.
Photo by ©iStockphoto.com/Rixipix
Robby Gardner
Associate Editor
Nutritional Outlook magazine
robby.gardner@ubm.com
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.